About Biomatter
Biomatter is a Healthcare company based in Vilnius (Lithuania) founded in 2018 by Donatas Repecka and Laurynas Karpus. Provider of synthetic biology and AI-based technology for generative protein design. It operates in the Healthcare and Technology sectors. Biomatter has raised $7.73 million across 2 funding rounds from investors including 70V, UVC Partners and Inventure VC. Its chief executive, as recorded, is Laurynas Karpus. Biomatter offers products and services including Protein Architecture and Biotech Tools. Its focus areas include Biopharma Outsourcing, Diversified, Small Molecules & Peptides and Life Sciences. Its legal entity is Biomatter Inc.
Company details
Biomatter was founded in 2018 in Vilnius, Lithuania, as a provider of synthetic biology and AI-based tools for generative protein design. An Intelligent Architecture platform is utilized to enable sequence- and structure-based redesign of existing proteins. Operations focus on applications in therapeutics, agriculture, molecular biology tools, food, and beverages, supporting advancements in these sectors through precise protein engineering.
- Headquarters Vilnius, Lithuania
- Founders Donatas Repecka, Laurynas Karpus
- SectorsHealthcareTechnology
- Email••••••••
- Website biomatter.ai
- Social LinkedIn X
- Legal Name Biomatter Inc
- Total Equity Funding$7.73M (USD)
in 2 rounds
- Latest Funding Round$7.12M (USD), Seed
Aug 2024
- Investors70V
& 3 more
Products & Services of Biomatter
Biomatter offers a comprehensive portfolio of products and services, including Protein Architecture and Biotech Tools.
Protein design and engineering services are provided for various applications
Tools and equipment related to protein work are supplied in the biotechnology sector
Funding Insights of Biomatter
Biomatter has successfully raised a total of $7.73M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $7.12 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.73M
- Total Rounds 2
- Last Round Seed — $7.12M
- First Round $610,755
(Jan 2021)
- Investors Count 4
All 2 funding rounds of Biomatter with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2024 | $7.12M | Seed | – | UVC Partners | |
| Jan 2021 | $610,755 | Seed | – | Practica Capital |
4 investors in total: 4 institutional.
Investors in Biomatter
Biomatter has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include 70V, UVC Partners and Inventure VC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are directed toward enterprise software, mobility, and industrial technologies. | uvcpartners.com | Munich, Germany | ||
Investments in early-stage tech startups are made by Inventure. | inventure.vc | Helsinki, Finland | ||
Seed to growth VC firm funding companies in the Baltics | practica.vc | Vilnius, Lithuania | ||
B2B startups are accelerated through focused programs by 70V. | 2018 | 70v.com | Vilnius, Lithuania |
Investor details for Biomatter
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biomatter
2 people are tracked at Biomatter (2 in leadership).
| Name | Role | Group |
|---|---|---|
Donatas Repecka | Co-Founder | Leadership |
Laurynas Karpus | Co-Founder & CEO | Leadership |
Complete people profiles for Biomatter
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biomatter
3 dated milestones of Biomatter across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Biomatter is founded.
- Funding First funding round of $611K.
- Funding Latest funding round, Seed, of $7.1M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biomatter
Biomatter was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Biomatter is headquartered in Vilnius, Lithuania.
Laurynas Karpus is the CEO of Biomatter, as recorded in our data. They have also founded this company.
Biomatter is a funded company, having raised a total of $7.73M across 2 funding rounds to date. The company's 1st funding round was a Seed of $610.76K, raised on Jan 2021.
Biomatter was founded in 2018 in Vilnius, Lithuania, as a provider of synthetic biology and AI-based tools for generative protein design. An Intelligent Architecture platform is utilized to enable sequence- and structure-based redesign of existing proteins. Operations focus on applications in therapeutics, agriculture, molecular biology tools, food, and beverages, supporting advancements in these sectors through precise protein engineering.
Biomatter offers Protein Architecture and Biotech Tools.
Biomatter has 4 investors. Key investors include 70V, UVC Partners, Inventure VC, and Practica Capital.
Biomatter operates through Biomatter Inc.